Get Real Time Here
| Open49.330 | Close48.690 |
| Vol / Avg.742.018K / 1.115M | Mkt Cap6.986B |
| Day Range48.510 - 49.460 | 52 Wk Range32.690 - 51.890 |
Ionis Pharmaceuticals Stock (NASDAQ:IONS), Quotes and News Summary
Ionis Pharmaceuticals Stock (NASDAQ: IONS) stock price, news, charts, stock research, profile.
| Open49.330 | Close48.690 |
| Vol / Avg.742.018K / 1.115M | Mkt Cap6.986B |
| Day Range48.510 - 49.460 | 52 Wk Range32.690 - 51.890 |
Earnings
see more| Q4 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -1.070 | -0.850 | 0.2200 | ||||
| REV | 132.900M | 144.000M | 11.100M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-11-17 | Needham | Joseph Stringer | Reiterates | BuyBuy | Maintains | - | 60.00 |
| 2023-11-03 | Goldman Sachs | Salveen Richter | Maintains | SellSell | Raises | 25.00 | 28.00 |
| 2023-11-03 | Morgan Stanley | Michael Ulz | Maintains | Equal-WeightEqual-Weight | Raises | 45.00 | 48.00 |
| 2023-10-23 | B of A Securities | Jason Gerberry | Upgrades | UnderperformNeutral | Raises | 33.00 | 52.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| IONS | Ionis Pharmaceuticals | -1.58% | 7B |
| IMVT | Immunovant | -2.68% | 5.7B |
| LEGN | Legend Biotech | -3.48% | 10.8B |
| EXAS | Exact Sciences | -0.37% | 11.7B |
| SRPT | Sarepta Therapeutics | -2.1% | 8.1B |
How do I buy Ionis Pharmaceuticals (IONS) stock?
You can purchase shares of Ionis Pharmaceuticals (NASDAQ: IONS) through any online brokerage.
Who are Ionis Pharmaceuticals's (IONS) competitors?
Other companies in Ionis Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT) and Neurocrine Biosciences (NASDAQ:NBIX).
What is the target price for Ionis Pharmaceuticals (IONS) stock?
The latest price target for Ionis Pharmaceuticals (NASDAQ: IONS) was reported by Needham on Friday, November 17, 2023. The analyst firm set a price target for 60.00 expecting IONS to rise to within 12 months (a possible 23.23% upside). 29 analyst firms have reported ratings in the last year.
Current Stock Price for Ionis Pharmaceuticals (IONS)?
The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $48.69 last updated December 8, 2023 at 9:00 PM UTC.
Does Ionis Pharmaceuticals (IONS) pay a dividend?
There is no dividend information for Ionis Pharmaceuticals.
When is Ionis Pharmaceuticals (NASDAQ:IONS) reporting earnings?
Ionis Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, February 21, 2024.
Is Ionis Pharmaceuticals (IONS) going to split?
There is no upcoming split for Ionis Pharmaceuticals.
What sector and industry does Ionis Pharmaceuticals (IONS) operate in?
Ionis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.